0.1% Tacrolimus ointment in the treatment of discoid lupus erythematosus

Archives of Dermatology

Volumn 141, Issue 9, 2005, Pages 1170-1171

  Heffernan, Michael P ^a   Nelson, Michael M ^b   Smith, David I ^b   Chung, Jonathan H ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLOBETASOL PROPIONATE; TACROLIMUS;

CLINICAL ARTICLE; DISCOID LUPUS ERYTHEMATOSUS; ERYTHEMA; HUMAN; NOTE; PILOT STUDY; PRIORITY JOURNAL; SCAR FORMATION; SIDE EFFECT;

ADMINISTRATION, TOPICAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, DISCOID; OINTMENTS; TACROLIMUS;

EID: 25444437498     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.141.9.1170     Document Type: Note

References (4)

1. Walker SL, Kirby B, Chalmers RJ. The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol. 2002;147:405-406.
2. de la Rosa Carrillo D, Christensen OB. Treatment of chronic discoid lupus erythematosus with topical tacrolimus. Acta Derm Venereol. 2004;84:233-234.
3. Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D'Cruz DP. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford). 2004;43:1383-1385.
4. Yoshimasu T, Ohtani T, Sakamoto T, Oshima A, Furukawa F. Topical FK506 (tacrolimus) therapy for facial erythematous lesions of cutaneous lupus erythematosus and dermatomyositis. Eur J Dermatol. 2002;12:50-52.